# SNP-based Microdeletion and Aneuploidy RegisTry (SMART)

> **NCT02381457** · — · COMPLETED · sponsor: **Natera, Inc.** · enrollment: 20960 (actual)

## Conditions studied

- 22q11 Deletion Syndrome
- DiGeorge Syndrome
- Trisomy 21
- Trisomy 18
- Trisomy 13
- Monosomy X
- Sex Chromosome Abnormalities
- Cri-du-Chat Syndrome
- Angelman Syndrome
- Prader-Willi Syndrome
- 1p36 Deletion Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02381457
- **Lead sponsor:** Natera, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 20960 (ACTUAL)
- **Last updated:** 2021-01-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02381457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02381457, "SNP-based Microdeletion and Aneuploidy RegisTry (SMART)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02381457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*